Pavan Cheruvu

Pavan Cheruvu, MD, is Axovant’s Chief Executive Officer. Dr. Cheruvu previously held roles of increasing responsibility at Roivant Sciences and was appointed to the company’s executive leadership team in 2017. He supported Axovant in numerous capacities throughout his tenure at Roivant. A board-certified physician, Dr. Cheruvu completed his residency in internal medicine at Johns Hopkins Hospital and continued his training in a clinical fellowship in cardiovascular medicine at the University of California, San Francisco. Prior to his medical training, Dr. Cheruvu was a management consultant at McKinsey & Company, where he focused on biopharmaceutical strategy. Dr. Cheruvu earned his B.S.E. in biomedical engineering, B.S.E. in electrical engineering, and A.B. in chemistry summa cum laude from Duke University, obtained his M.Sc. in computer science as a Rhodes Scholar at Oxford University, and obtained his M.D. from Harvard Medical School.